Free Trial

Booz Allen Hamilton (BAH) Competitors

Booz Allen Hamilton logo
$107.29 -5.76 (-5.10%)
Closing price 07/28/2025 03:59 PM Eastern
Extended Trading
$107.36 +0.07 (+0.07%)
As of 07/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAH vs. CCRN, CACI, LDOS, SAIC, CTSH, IT, DOX, EPAM, TDC, and HCKT

Should you be buying Booz Allen Hamilton stock or one of its competitors? The main competitors of Booz Allen Hamilton include Cross Country Healthcare (CCRN), CACI International (CACI), Leidos (LDOS), Science Applications International (SAIC), Cognizant Technology Solutions (CTSH), Gartner (IT), Amdocs (DOX), EPAM Systems (EPAM), Teradata (TDC), and The Hackett Group (HCKT).

Booz Allen Hamilton vs. Its Competitors

Cross Country Healthcare (NASDAQ:CCRN) and Booz Allen Hamilton (NYSE:BAH) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Booz Allen Hamilton has a net margin of 8.70% compared to Cross Country Healthcare's net margin of -1.41%. Booz Allen Hamilton's return on equity of 71.88% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-1.41% 2.56% 1.84%
Booz Allen Hamilton 8.70%71.88%11.68%

Cross Country Healthcare has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Booz Allen Hamilton has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500.

Cross Country Healthcare currently has a consensus price target of $17.93, suggesting a potential upside of 29.83%. Booz Allen Hamilton has a consensus price target of $134.00, suggesting a potential upside of 24.90%. Given Cross Country Healthcare's higher probable upside, analysts clearly believe Cross Country Healthcare is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Booz Allen Hamilton
2 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.25

In the previous week, Booz Allen Hamilton had 40 more articles in the media than Cross Country Healthcare. MarketBeat recorded 44 mentions for Booz Allen Hamilton and 4 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.87 beat Booz Allen Hamilton's score of 0.78 indicating that Cross Country Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Booz Allen Hamilton
18 Very Positive mention(s)
4 Positive mention(s)
14 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.9% of Booz Allen Hamilton shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.34B0.34-$14.56M-$0.53-26.06
Booz Allen Hamilton$11.98B1.11$935M$8.1413.18

Summary

Booz Allen Hamilton beats Cross Country Healthcare on 13 of the 17 factors compared between the two stocks.

Get Booz Allen Hamilton News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAH vs. The Competition

MetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE Exchange
Market Cap$14.04B$7.42B$14.97B$21.14B
Dividend Yield1.95%1.74%2.73%3.59%
P/E Ratio13.1824.3629.1228.31
Price / Sales1.112.8349.6755.92
Price / Cash14.6117.4526.7218.21
Price / Book13.555.866.574.70
Net Income$935M$272.15M$197.16M$992.76M
7 Day Performance-4.07%-2.09%-0.09%0.62%
1 Month Performance4.01%0.52%5.25%4.54%
1 Year Performance-25.68%-9.38%25.70%10.20%

Booz Allen Hamilton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAH
Booz Allen Hamilton
4.884 of 5 stars
$107.29
-5.1%
$134.00
+24.9%
-23.3%$14.04B$11.98B13.1835,800Earnings Report
Dividend Announcement
Analyst Forecast
High Trading Volume
CCRN
Cross Country Healthcare
3.628 of 5 stars
$13.36
+4.5%
$17.93
+34.2%
-16.4%$437.94M$1.34B-25.218,205Upcoming Earnings
CACI
CACI International
3.3894 of 5 stars
$478.60
-0.9%
$520.31
+8.7%
+3.1%$10.52B$7.66B22.5924,000
LDOS
Leidos
4.4314 of 5 stars
$160.76
-1.1%
$175.15
+9.0%
+7.1%$20.69B$16.93B16.1748,000Positive News
SAIC
Science Applications International
3.8827 of 5 stars
$112.54
-0.8%
$124.73
+10.8%
-7.3%$5.28B$7.51B18.9826,000Positive News
CTSH
Cognizant Technology Solutions
4.9009 of 5 stars
$75.42
-0.3%
$86.18
+14.3%
+1.1%$37.18B$19.74B15.88336,800Positive News
Upcoming Earnings
Analyst Forecast
IT
Gartner
4.6989 of 5 stars
$352.95
-0.7%
$507.56
+43.8%
-25.1%$27.17B$6.30B21.9621,044
DOX
Amdocs
4.7757 of 5 stars
$88.03
-1.6%
$105.33
+19.7%
-0.1%$9.94B$5.00B18.5329,058Positive News
EPAM
EPAM Systems
4.9463 of 5 stars
$165.60
+0.5%
$231.73
+39.9%
-19.7%$9.38B$4.73B23.1661,200Positive News
TDC
Teradata
2.751 of 5 stars
$21.53
-0.3%
$27.25
+26.6%
-30.0%$2.06B$1.75B15.165,700Positive News
HCKT
The Hackett Group
4.0306 of 5 stars
$23.23
-0.4%
$31.33
+34.9%
-10.8%$642.54M$313.86M27.331,478

Related Companies and Tools


This page (NYSE:BAH) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners